[1]
“ Obligations, precautions and pending issues in regulatory development for radiopharmaceuticals in Brazil ”, Braz. J. Pharm. Sci., vol. 50, no. 2, pp. 285–290, Apr. 2014, doi: 10.1590/S1984-82502014000200007.